Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Shares Issued (2018 - 2025)

vTv Therapeutics (VTVT) has disclosed Shares Issued for 7 consecutive years, with -$9000.0 as the latest value for Q3 2025.

  • Quarterly Shares Issued fell 100.37% to -$9000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, changed 0.37% year-over-year, with the annual reading at $2.5 million for FY2024, N/A changed from the prior year.
  • Shares Issued hit -$9000.0 in Q3 2025 for vTv Therapeutics, down from $2.5 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $26.7 million in Q4 2021 to a low of -$5.0 million in Q4 2022.
  • Historically, Shares Issued has averaged $6.6 million across 4 years, with a median of $2.5 million in 2024.
  • Biggest five-year swings in Shares Issued: surged 580.0% in 2021 and later plummeted 118.87% in 2022.
  • Year by year, Shares Issued stood at $26.7 million in 2021, then plummeted by 118.87% to -$5.0 million in 2022, then surged by 148.87% to $2.5 million in 2024, then plummeted by 100.37% to -$9000.0 in 2025.
  • Business Quant data shows Shares Issued for VTVT at -$9000.0 in Q3 2025, $2.5 million in Q3 2024, and -$5.0 million in Q4 2022.